in Newswire November 14, 2019

Class Action Claims Sanofi Knowingly Sold Zantac Contaminated with Probable Carcinogen

by Erin Shaak

Last Updated on November 14, 2019

Melillo v. Sanofi-Aventis U.S. LLC et al.

Filed: November 12, 2019 § 1:19-cv-06376

A proposed class action claims Sanofi knowingly manufactured and sold Zantac contaminated with the probable carcinogen N-Nitrosodimethylamine (NDMA).



New York

Last Updated on November 14, 2019 — 4:11 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.